These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

693 related items for PubMed ID: 27993133

  • 1. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer.
    Dobiasch S, Szanyi S, Kjaev A, Werner J, Strauss A, Weis C, Grenacher L, Kapilov-Buchman K, Israel LL, Lellouche JP, Locatelli E, Franchini MC, Vandooren J, Opdenakker G, Felix K.
    J Nanobiotechnology; 2016 Dec 19; 14(1):81. PubMed ID: 27993133
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer.
    Grünwald B, Vandooren J, Locatelli E, Fiten P, Opdenakker G, Proost P, Krüger A, Lellouche JP, Israel LL, Shenkman L, Comes Franchini M.
    J Control Release; 2016 Oct 10; 239():39-48. PubMed ID: 27545397
    [Abstract] [Full Text] [Related]

  • 3. Targeted diagnostic magnetic nanoparticles for medical imaging of pancreatic cancer.
    Rosenberger I, Strauss A, Dobiasch S, Weis C, Szanyi S, Gil-Iceta L, Alonso E, González Esparza M, Gómez-Vallejo V, Szczupak B, Plaza-García S, Mirzaei S, Israel LL, Bianchessi S, Scanziani E, Lellouche JP, Knoll P, Werner J, Felix K, Grenacher L, Reese T, Kreuter J, Jiménez-González M.
    J Control Release; 2015 Sep 28; 214():76-84. PubMed ID: 26192099
    [Abstract] [Full Text] [Related]

  • 4. The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.
    Wang SS, Chou NK, Chung TW.
    J Biomed Mater Res A; 2009 Dec 28; 91(3):753-61. PubMed ID: 19051299
    [Abstract] [Full Text] [Related]

  • 5. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.
    Chung TW, Wang SS, Tsai WJ.
    Biomaterials; 2008 Jan 28; 29(2):228-37. PubMed ID: 17953984
    [Abstract] [Full Text] [Related]

  • 6. Superparamagnetic iron oxide--loaded poly(lactic acid)-D-alpha-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent.
    Prashant C, Dipak M, Yang CT, Chuang KH, Jun D, Feng SS.
    Biomaterials; 2010 Jul 28; 31(21):5588-97. PubMed ID: 20434210
    [Abstract] [Full Text] [Related]

  • 7. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J, Pei Y, Hyun H, Castanares MA, Collins DS, Yeo Y.
    J Control Release; 2017 Dec 28; 268():407-415. PubMed ID: 29111150
    [Abstract] [Full Text] [Related]

  • 8. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T, Yu X, Carbone EJ, Nelson C, Kan HM, Lo KW.
    Int J Pharm; 2014 Nov 20; 475(1-2):547-57. PubMed ID: 25194353
    [Abstract] [Full Text] [Related]

  • 9. Preparation and Characterization of PLGA-based Magnetic Polymer Nanoparticles for Targeting Pancreatic Adenocarcinoma.
    Lu L, Jie L, Zhou Y, Zhang J, Feng T, Zhu Y, Chen T, Zhu X, Ji J, Wang Z.
    Curr Pharm Des; 2023 Nov 20; 29(9):686-696. PubMed ID: 36967466
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer.
    Arya G, Das M, Sahoo SK.
    Biomed Pharmacother; 2018 Jun 20; 102():555-566. PubMed ID: 29597089
    [Abstract] [Full Text] [Related]

  • 11. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
    Ma J, Shen M, Xu CS, Sun Y, Duan YR, Du LF.
    Oncotarget; 2016 Nov 29; 7(48):80008-80018. PubMed ID: 27835907
    [Abstract] [Full Text] [Related]

  • 12. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
    Parveen S, Sahoo SK.
    Eur J Pharmacol; 2011 Nov 30; 670(2-3):372-83. PubMed ID: 21951969
    [Abstract] [Full Text] [Related]

  • 13. LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors.
    Luo G, Yu X, Jin C, Yang F, Fu D, Long J, Xu J, Zhan C, Lu W.
    Int J Pharm; 2010 Jan 29; 385(1-2):150-6. PubMed ID: 19825404
    [Abstract] [Full Text] [Related]

  • 14. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
    Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC.
    Biomaterials; 2007 Feb 29; 28(5):869-76. PubMed ID: 17055572
    [Abstract] [Full Text] [Related]

  • 15. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, Li F, Hu H, Yang S.
    Biomaterials; 2011 Jul 29; 32(20):4584-93. PubMed ID: 21458063
    [Abstract] [Full Text] [Related]

  • 16. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
    Wang T, Kievit FM, Veiseh O, Arami H, Stephen ZR, Fang C, Liu Y, Ellenbogen RG, Zhang M.
    World Neurosurg; 2013 Jul 29; 80(1-2):134-41. PubMed ID: 23298674
    [Abstract] [Full Text] [Related]

  • 17. Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification.
    Zhang S, Tang C, Yin C.
    Drug Deliv; 2015 Feb 29; 22(2):182-90. PubMed ID: 24215373
    [Abstract] [Full Text] [Related]

  • 18. Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging.
    Yuk SH, Oh KS, Cho SH, Lee BS, Kim SY, Kwak BK, Kim K, Kwon IC.
    Biomacromolecules; 2011 Jun 13; 12(6):2335-43. PubMed ID: 21506550
    [Abstract] [Full Text] [Related]

  • 19. Magnetic core-shell hybrid nanoparticles for receptor targeted anti-cancer therapy and magnetic resonance imaging.
    Shanavas A, Sasidharan S, Bahadur D, Srivastava R.
    J Colloid Interface Sci; 2017 Jan 15; 486():112-120. PubMed ID: 27697648
    [Abstract] [Full Text] [Related]

  • 20. Targeting of peptide conjugated magnetic nanoparticles to urokinase plasminogen activator receptor (uPAR) expressing cells.
    Hansen L, Larsen EK, Nielsen EH, Iversen F, Liu Z, Thomsen K, Pedersen M, Skrydstrup T, Nielsen NC, Ploug M, Kjems J.
    Nanoscale; 2013 Sep 07; 5(17):8192-201. PubMed ID: 23835641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.